QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction

Autor: Boitard, Solène E., Keck, Mathilde, Deloux, Robin, Girault-Sotias, Pierre-Emmanuel, Marc, Yannick, De Mota, Nadia, Compere, Delphine, Agbulut, Onnik, Balavoine, Fabrice, Llorens-Cortes, Catherine

Publikováno v: In Canadian Journal of Cardiology June 2022 38(6):815-827

Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

Autor: Piquereau J; UMR-S 1180, Inserm Unit of Signaling and Cardiovascular Pathophysiology, Faculty of Pharmacy, Université Paris-Saclay, 92296 Chatenay-Malabry, France., Boitard SE; UMR-S 1180, Inserm Unit of Signaling and Cardiovascular Pathophysiology, Faculty of Pharmacy, Université Paris-Saclay, 92296 Chatenay-Malabry, France., Ventura-Clapier R; UMR-S 1180, Inserm Unit of Signaling and Cardiovascular Pathophysiology, Faculty of Pharmacy, Université Paris-Saclay, 92296 Chatenay-Malabry, France., Mericskay M; UMR-S 1180, Inserm Unit of Signaling and Cardiovascular Pathophysiology, Faculty of Pharmacy, Université Paris-Saclay, 92296 Chatenay-Malabry, France.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 21; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 21.